News

Marcus Samuelsson: From TB to Top Chef


1 Jul 2012
by Working Group

This post originally appeared on NPR – click here to listen to the interview and read the full story

Marcus Samuelsson owns two restaurants in New York City and two restaurants in Sweden. He’s cooked for President Obama and prime ministers, served as a judge on Top Chef andChopped, and recently competed against 21 other chefs on Top Chef Masters. (He won.) He’s the youngest chef ever to receive two three-star ratings from The New York Times.

Samuelsson’s journey to some of the most celebrated restaurants in the U.S. was a long one — and started several thousand miles away. He was born in rural Ethiopia, where he contracted tuberculosis when he was 3 years old. His mother, who was also battling the disease, walked with Samuelsson and his sister 75 miles to a hospital in Addis Ababa. Though Samuelsson and his sister recovered, their mother did not. After her death, both Samuelsson children were adopted by a family in Sweden.

Samuelsson details his path from Sweden, where he learned to cook from his grandmother Helga, to New York City and the Food Network in his memoir, Yes, Chef — in which he pays homage to his Swedish family and to food.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...